Aljuhani, M.; Ashraf, A.; Alqarni, A.; Alshuhri, M.S.; Alkhybari, E.M.; Alharbi, A.; Almudayni, A.; Alablani, F.J.; Akhmimi, A.; Alhulail, A.A.
Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer’s Disease: Longitudinal Evidence from the ADNI Cohort. Neurol. Int. 2026, 18, 138.
https://doi.org/10.3390/neurolint18070138
AMA Style
Aljuhani M, Ashraf A, Alqarni A, Alshuhri MS, Alkhybari EM, Alharbi A, Almudayni A, Alablani FJ, Akhmimi A, Alhulail AA.
Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer’s Disease: Longitudinal Evidence from the ADNI Cohort. Neurology International. 2026; 18(7):138.
https://doi.org/10.3390/neurolint18070138
Chicago/Turabian Style
Aljuhani, Manal, Azhaar Ashraf, Abdullah Alqarni, Mohammed S. Alshuhri, Essam Mohammed Alkhybari, Amani Alharbi, Alanoud Almudayni, Fatmah Jamal Alablani, Azhar Akhmimi, and Ahmad A. Alhulail.
2026. "Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer’s Disease: Longitudinal Evidence from the ADNI Cohort" Neurology International 18, no. 7: 138.
https://doi.org/10.3390/neurolint18070138
APA Style
Aljuhani, M., Ashraf, A., Alqarni, A., Alshuhri, M. S., Alkhybari, E. M., Alharbi, A., Almudayni, A., Alablani, F. J., Akhmimi, A., & Alhulail, A. A.
(2026). Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer’s Disease: Longitudinal Evidence from the ADNI Cohort. Neurology International, 18(7), 138.
https://doi.org/10.3390/neurolint18070138